ASSOCIATION OF MATRIX METALLOPROTEINASE 2 (MMP2) BASELINE PLASMA LEVEL WITH RESPONSE AND SURVIVAL AND CHANGE OVERTIME IN PATIENTS TREATED WITH BEVACIZUMAB FOR RECURRENT HIGH GRADE GLIOMA

BACKGROUND: Predictive marker of bevacizumab activity is an unmet medical need. We evaluated predictive value of selected circulating prebiomarkers involved in neoangiogenesis and invasion on patient outcome in recurrent high grade glioma (HGG) treated with bevacizumab. METHODS: A set of eleven preb...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Chinot, Olivier-L, Boudouresque, Françoise, Barrie, Maryline, Matta, Mona, Boucard, Celine, Loundou, Anderson, Figarella-Branger, Dominique, Ouafik, L'Houcine, Tabouret, Emeline
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2014
Teme:
abstracts
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4144637/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou209.23
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items